What is the Market's View on CEL-SCI Corporation (CVM) Stock's Price and Volume Trends Wednesday?

Overall market sentiment has been down on CEL-SCI Corporation (CVM) stock lately. CVM receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.

CEL-SCI Corporation has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on CVM!

See Full CVM Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With CVM Stock Today?

CEL-SCI Corporation (CVM) stock is trading at $3.95 as of 4:00 PM on Wednesday, Mar 30, a decline of -$0.11, or -2.71% from the previous closing price of $4.06. The stock has traded between $3.89 and $4.12 so far today. Volume today is below average. So far 452,145 shares have traded compared to average volume of 824,544 shares. To screen for more stocks like CEL-SCI Corporation click here.

More About CEL-SCI Corporation

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia. Click Here to get the full Stock Report for CEL-SCI Corporation stock.